Fred B Craves insider trades: Madrigal Pharmaceuticals (MDGL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Fred reports to the SEC
and 2 more companies
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | MDGL | ↓ Sell | 15,470 | $328.54 | $5.1M | Direct | Mar 14, 2025 (1d) |
| Dec 3, 2024 | MDGL | ↓ Sell | 3,600 | $315.31 | $1.1M | Indirect | Dec 5, 2024 (2d) |
| Nov 25, 2024 | MDGL | ↓ Sell | 3,400 | $350.30 | $1.2M | Indirect | Nov 27, 2024 (2d) |
| May 14, 2024 | MDGL | ↓ Sell | 22,489 | $212.88 | $4.8M | Direct | May 16, 2024 (2d) |
| Aug 19, 2020 | MDGL | ↓ Sell | 30,000 | $109.74 | $3.3M | Indirect | Aug 19, 2020 (0d) |
| Dec 13, 2019 | MDGL | ↓ Sell | 1,200,000 | $105.47 | $126.6M | Indirect | Dec 13, 2019 (0d) |
| Nov 19, 2018 | MDGL | ↑ Buy | 2,000 | $124.69 | $249K | Direct | Nov 19, 2018 (0d) |
| Jun 11, 2018 | MDGL | ↓ Sell | 280,000 | $287.46 | $80.5M | Indirect | Jun 12, 2018 (1d) |
| Aug 14, 2017 | DERM | ↑ Buy | 30,000 | $23.03 | $691K | Fred Craves Family Foundation | Aug 14, 2017 (0d) |
| Oct 8, 2014 | DERM | ↑ Buy | 69,112 | $16.00 | $1.1M | Indirect | Oct 8, 2014 (0d) |
| Mar 27, 2009 | PARD | ↑ Buy | 5,000 | $2.14 | $11K | Direct | Mar 30, 2009 (3d) |
| Mar 26, 2009 | PARD | ↑ Buy | 15,000 | $2.10 | $32K | Direct | Mar 30, 2009 (4d) |
| Dec 22, 2008 | PARD | ↑ Buy | 2,900 | $1.76 | $5K | Direct | Dec 23, 2008 (1d) |
| Dec 19, 2008 | PARD | ↑ Buy | 25,000 | $1.75 | $44K | Direct | Dec 23, 2008 (4d) |
| Dec 18, 2008 | PARD | ↑ Buy | 26,500 | $1.90 | $50K | Direct | Dec 19, 2008 (1d) |
| Dec 17, 2008 | PARD | ↑ Buy | 13,000 | $1.91 | $25K | Direct | Dec 17, 2008 (0d) |
| Dec 16, 2008 | PARD | ↑ Buy | 11,900 | $1.96 | $23K | Direct | Dec 17, 2008 (1d) |
| Jan 11, 2008 | PARD | ↑ Buy | 12,600 | $3.98 | $50K | Direct | Jan 14, 2008 (3d) |
| Jan 9, 2008 | PARD | ↑ Buy | 20,000 | $4.24 | $85K | Direct | Jan 10, 2008 (1d) |
| Jan 4, 2008 | PARD | ↑ Buy | 11,300 | $4.22 | $48K | Direct | Jan 7, 2008 (3d) |
| Jan 3, 2008 | PARD | ↑ Buy | 20,000 | $4.27 | $85K | Direct | Jan 7, 2008 (4d) |
| Aug 30, 2007 | PARD | ↑ Buy | 5,344 | $5.90 | $32K | Indirect | Aug 31, 2007 (1d) |
| Aug 29, 2007 | PARD | ↑ Buy | 352 | $5.75 | $2K | Indirect | Aug 31, 2007 (2d) |
| Aug 16, 2007 | PARD | ↑ Buy | 368 | $5.49 | $2K | Indirect | Aug 16, 2007 (0d) |
| Aug 10, 2007 | PARD | ↑ Buy | 972 | $5.50 | $5K | Indirect | Aug 14, 2007 (4d) |
| Apr 30, 2007 | PARD | ↑ Buy | 79,498 | $6.33 | $503K | Indirect | Apr 30, 2007 (0d) |
| Apr 26, 2006 | NERX | ↑ Buy | 1,792,054 | $0.70 | $1.3M | Indirect | Apr 28, 2006 (2d) |
| Jul 22, 2005 | MEDX | ↓ Sell | 14,000 | $10.05 | $141K | Direct | Jul 25, 2005 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDGL insiders
Open-market trades in the last 12 months
About Fred B Craves's insider trades
Fred B Craves is a director at Madrigal Pharmaceuticals (MDGL). Since Jul 22, 2005, Fred has reported 20 open-market purchases worth $4.3M and 8 sales worth $222.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (26 filings), other transactions (10 filings), option exercises (6 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.